Helius Medical Technologies, Inc. is a neurotechnology company. The Company is engaged in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS), is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy utilizes the PoNS device in conjunction with supervised therapeutic exercise. The PoNS Therapy consists of condition-specific exercises for movement control, including balance and gait training and breathing and awareness training, which are tailored to focus on the individual patient’s functional deficits.
Código de la empresaHSDT
Nombre de la empresaHelius Medical Technologies Inc
Fecha de salida a bolsaJun 27, 2014
Fundada en2018
Director ejecutivoMr. Dane C. Andreeff
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 27
Dirección642 Newtown Yardley Road
CiudadNEWTOWN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal18940
Teléfono12159446100
Sitio Webhttps://heliusmedical.com/
Código de la empresaHSDT
Fecha de salida a bolsaJun 27, 2014
Fundada en2018
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos